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Plicosepalus is an important genus of the Loranthaceae family, and it is a semiparasitic plant grown in Saudi Arabia, traditionally
used as a cure for diabetes and cancer in human and for increasing lactation in cattle. A flavonoid quercetin (P1), (-)-catechin
(P2), and a flavane gallate 2S,3R-3,3′,4′,5,7-pentahydroxyflavane-5-O-gallate (P3) were isolated from the methanol extract of the
aerial parts of P. curviflorus (PCME).)e PCME and the isolated compounds were subjected to pharmacological assays to estimate
peroxisome proliferator-activated receptors PPARα and PPARc agonistic, anti-inflammatory, cytotoxic, and antimicrobial
activities. Results proved for the first time the dual PPAR activation effect of the PCME and catechin (P2), in addition to the
promising anti-inflammatory activity of the flavonoid quercetin (P1). Interestingly, both PCME and isolated compounds showed
potent antioxidant activities while no antimicrobial effect against certain microbial strains had been reported from the extract and
the isolated compounds. Based on the pharmacological importance of these compounds, an HPTLC validated method was
developed for the simultaneous estimation of these compounds in PCME. It was found to furnish a compact and sharp band of
compounds P1, P2, and P3 at Rf � 0.34, 0.47, and 0.65, respectively, using dichloromethane, methanol, and formic acid (90 : 9.5 :
0.5, (v/v/v)) as the mobile phase. Compounds P1, P2, and P3were found to be 11.06, 10.9, 6.96 μg/mg, respectively, in PCME.)e
proposed HPTLC method offers a sensitive, precise, and specific analytical tool for the quantification of quercetin, catechin, and
flavane gallates in P. curviflorus.
1. Introduction
Flavonoids and flavane gallates are naturally occurring
secondary metabolites in the plant species. )ey present in
good amounts in dietary supplements and functional food.
Quercetin is one of the important bioflavonoids present in
many ethnic plants. Quercetin has importance in terms of
ethnopharmacology due to its use as anti-inflammatory,
antioxidant, anticancer, antiobesity, and antiathero-
sclerotic activities [1, 2].
)e flavane gallates, catechins, and their derivatives have
attracted attention in terms of beneficial effects on human
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health, due to their high availability, less toxic effect, and low
cost [3]. Previous investigations on catechins reported dif-
ferent types of biological activities such as antitumor,
antioxidative, and antimicrobial activities [4, 5].
Plicosepalus curviflorus is one of the two known species
grown in Saudi Arabia and belongs to Loranthaceae family.
)is parasitic plant found to be growing in East Africa,
North East Africa, Saudi Arabia, and Yemen [6, 7]. In the
traditional system of medicine, the stems were valued for
cancer in Yemen [7, 8], while the leaves of the plant were
reported for curing diabetes in Saudi Arabia [9]. Various
phytochemical studies of crude leaves of P. curviflorus
showed the presence of flavonoids, flavane gallates, sterols,
and terpenoids [10]. For instance, in our previous phyto-
chemical investigation on P. curviflorus growing in Saudi
Arabia, we isolated the quercetin (P1), catechin (P2), and
flavane gallate 2S, 3R-3,3′,4′,5,7-pentahydroxyflavane-5-O-
gallate (P3) (Figure 1) from the aerial parts of the plant and
proved their hypoglycemic effect [11].
Consequently, the present study was focused on further
pharmacological investigations of the plant extract and
isolated compounds in order to explore their peroxisome
proliferator-activated receptors PPARα and PPARc agnos-
tic, anti-inflammatory, cytotoxic, and antimicrobial effects
to verify its traditional uses and try to refer activities to the
isolated compounds.
)e HPTLC (high-performance thin-layer chromatog-
raphy) has been widely used recently in the quality control of
herbs and their formulations due to its low operation cost,
high sample throughput, and small mobile phase re-
quirement. Different wavelengths of light which observed
with specific types of analyses can give a complete profile of
the plant extract. It is widely used for the identification,
stability, dissolution, purity testing, or content uniformity of
crude extracts of the plant [12].
)e good pharmacological activities shown by the
methanol extract of P. curviflorus and its isolated com-
pounds (P1, P2, and P3) motivated the authors for con-
current analysis of biomarkers P1, P2, and P3 in the
methanol extract of P. curviflorus by a validated HPTLC
method.
2. Materials and Methods
2.1. Phytochemical and Spectroscopic Procedures. All the
spectroscopic techniques used were the same as reported
earlier [11].
2.2. Plant Materials. )e aerial parts of P. curviflorus were
collected from Hijaz, Saudi Arabia, and identified by a plant
taxonomist of Pharmacy College, King Saud University. A
voucher specimen (No. 127) has been placed in the her-
barium of Pharmacognosy Department, King Saud
University.
2.2.1. Extraction and Phytochemical Isolation from P.
curviflorus. )e aerial parts of the plant (500 g) were ground
after shade-dried and successfully extracted with methanol
(2×1.5 L) at room temperature. Isolation of compounds P1,
P2, and P3 has been described in our previous published
article on the plant [11].
2.3. HPTLC Instrumentation and Conditions. )e HPTLC
analyses of compounds P1, P2, and P3 in P. curviflorus
methanol extract (PCME) were performed on (20×10 cm)
precoated silica gel F254 HPTLC plates. During the experiment,
the microliter syringe adjusted with the Automatic TLC
Sampler-4 was used for spotting the samples and the extract on
a HPTLC plate at a rate of 160nL/sec.)e plate was developed
under certain condition using GAMAC Automated De-
veloping Chamber-2 (ADC-2). In order to improve resolution
and separation of different compounds existing in P. curvi-
florus, a number of trials for best mobile phases combinations
were carried out. We found that dichloromethane :methanol :
formic acid in the ratio of 90 : 9.5 : 0.5 (v/v/v) is the appropriate
mobile phase mixture which was chosen to carry out the
analysis. )e following chamber saturation condition (at
25± 2°C and 60± 5% humidity) using a twin-trough glass
chamber (20×10 cm) was prepared for the development of the
plate. )en, the developed plate was dried and scanned by
GAMAG TLC Scanner-3 at λ� 460nm (wavelength) in the
mode of absorbance.
2.4. Preparation of Stock Solutions (Standards). Seven dif-
ferent concentrations (10, 20, 40, 60, 80, 100, and 120 µg/mL)
were prepared from the serial dilution of each standard P1,
P2, and P3 stock solutions (1mg/mL) dissolved in methanol.
In order to get a linearity range of 100–1200 ng/band, 10 μL
of each concentration of P1, P2, and P3 were spotted on the
HPTLC plate.
2.5.Validationof theMethod. )e projected HPTLCmethod
validation was prepared according to the ICH guideline
(ICH, 2005) for LOD (limit of detection), LOQ (limit of
quantification), precision, linearity range, robustness, re-
covery, and accuracy.
2.5.1. Accuracy. )e standard addition method was used to
determine accuracy. Compounds 1–3 (200 ng/band) were
spiked with the extra 0, 50, 100, and 150% of P1, P2, and P3,
and the solutions were reanalyzed in six replicates (n� 6) by
the proposed method. )e percent relative standard de-
viation (%RSD) and recovery took place.
2.5.2. Precision. )ree different concentration values 400,
600, and 800 ng/band of compounds P1, P2, and P3 were
prepared by duplicate analyses (n � 6) for calculation of
interday and intraday precision of the proposed method.
Intraday assays were repeated on three different days for
determination of the interday precision.
2.5.3. Robustness. Small deliberate changes were made to the
mobile phase composition, mobile phase volume, and du-
ration of mobile phase saturation for analyzing robustness.
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e results were determined in terms of %RSD and SD of
peak areas after three times repetition of the experiment at
300 ng/band. Dierent amounts of dichloromethane :
methanol : formic acid (v/v/v) were prepared for the
chromatography mobile phase. Activation of plates took
place for 30minutes at 110°C before chromatography
process.
2.5.4. LOQ and LOD. e slope (S) of the calibration curve
and the standard deviation (SD) of the response are pa-
rameters used to identify the LOQ and the LOD according to
the formula: LOQ 10 (SD/S) and LOD 3.3 (SD/S). Taking
into consideration that LOQ is the lowest amount that can
be determined at a distinct level of accuracy or precision and
the LOD is the minimum amount of an analyte that may be
calculated from the assay background at a distinct level of
condence.
2.5.5. Assay of Compounds P1, P2, and P3. Compounds P1,
P2, and P3 and PCME were applied on HPTLC plates. e
percentage of the three compounds present in PCME was
identied by calculating the area for the markers in PCME.
2.5.6. Statistical Analysis. e statistical analysis was used to
determine the total variation in a set of data. Two methods
were occupied for this purpose: Dunnet’s test and one-way
analysis of variance (ANOVA). e achieved results were
indicated as mean± SD; dierences were considered sig-
nicant at P values <0.05.
2.6. Biological Study
2.6.1. PPARα and PPARcAgonistic Activity. A reporter gene
assay was carried out as described previously [13]. Briey,
upon conuency, the dierent concentrations of the test
samples were exposed to transfected cells for 24 hrs. Vehicle
control was taken into consideration when the fold in-
duction in luciferase activity was calculated. Both rosigli-
tazone and ciprobrate were used as control drugs for
PPARα and PPARc, respectively.
2.6.2. Assay for Antioxidant Activity. Human hepatoma cell
line (HepG2) was the cell line of choice in this study
according to the previously described method [14]. At a
density of 60,000 cells/well, the HepG2 cells were seeded in a
96-well plate and incubated for 24 h for conuency. PBS was
used for washing the cells, followed by samples treatment.
e SpectraMax plate reader was used for reading the plates
after addition of 600 μM of ABAP. e area under the curve
(AUC) of uorescence units and time were two parameters
used for indication of the percent decrease in oxidative
stress. Percent decrease in oxidative stress 100− ((AUC
sample/AUC control)× 100). Quercetin was used as a
positive control.
2.6.3. Assay for iNOS Inhibition. Mouse macrophage
(RAW264.7) cells were seeded in the wells of 96-well plates
followed by 24 hrs for conuency according to the method
described previously [13, 14]. e test samples were treated
with LPS (5 μg/mL) and followed by 24-hour incubation as
well. e nitrite level in cell supernatant was measured by
Griess reagent. e dose response curves gave indication for
IC50 values. Parthenolide was used as positive control.
2.6.4. Reporter Gene Assay for Inhibition of NF-κB Activity.
According to the method described earlier [12, 13], the 96-
well plates with density of 1.25×105 cells per well were
seeded with human chondrosarcoma cells (SW1353)
transfected with NF-κB luciferase plasmid construct. After
incubation for 24 h, cells were treated with the test samples
for half an hour followed by PMA (70 ng/mL) for 8 h. Lu-
ciferase assay kit (Promega, Madison,WI, USA) was used for
determination of luciferase activity, and parthenolide was
used as the positive control in this test.
2.6.5. Assay for Cytotoxicity. Four human cancer cell lines
(SK-OV-3, SK-MEL, BT-549 and KB) and two non-
cancerous kidney cell lines (VERO and LLC-PK1) were
measured in the in vitro cytotoxic study. Test samples were
added on the cell lines with variable concentrations, followed
by 48 h incubation. According to the Borenfreund method,
the cell viability was determined at the end of incubation
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Figure 1: Structure of compounds P1, P2, and P3.
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2.6.6. Antimicrobial Assay. )e antimicrobial activity of
PCME and isolated compounds P1, P2, and P3 was assessed
against Gram-negative Enterobacter xiangfangensis
(CP017183.1), Escherichia fergusonii (CU928158.2), and
Pseudomonas aeruginosa (NR-117678.1) and Gram-positive
Staphylococcus aureus (CP011526.1) and Bacillus lichen-
iformis (KX785171.1) using well diffusion and broth
microdilution techniques as described by Berghe and
Vlietinck [16]. )e bacterial strains were suspended in a
nutrient broth for 24 hr, and the suspension then spread on
Mueller-Hinton agar. Wells were loaded with 10 µL of the
PCME, P1, P2, and P3. Amikacin was used as the positive
control. )e clear area which was free of microbial growth
was measured to detect the diameter of the zone of in-
hibition (mean of triplicates± SD), and the least concen-
tration of the PCME and P1, P2, and P3 that did not show
any visible growth of the bacteria in broth culture (MIC) was
calculated as well.
3. Results and Discussion
3.1. Biological Evaluation of PCME and P1, P2, and P3.
Genus Plicosepalus comprises two species in Saudi Arabia.
Previous work on this genus reported antiviral, antidiabetic,
and cytotoxic activities. Little phytochemical and biological
attention was drawn on the plant, and few previous studies
detected only the hypoglycemic and cytotoxic activities of P.
curviflorus extract and compounds [11, 17]. In this study, the
three compounds P1, P2, and P3 were obtained from PCME
after subjecting it to a series of silica gel and Sephadex LH-20
column chromatographic separations [11]. )e PCME and
isolated compounds P1, P2, and P3 were subjected to dif-
ferent biological investigations for concluding the complete
information about its active constitutes.
Fold induction in the PPAR activity was detected in
response to the methanol fraction and pure compounds
according to untreated controls. A fold induction of 1.5
means a 50% increase in PPAR activity. Dual activation
effect (a fold induction of 1.5 or more) was exhibited by
PCME and P2 (Table 1). Several studies have been carried
out with the aim of exploring the potential of selective
PPARc modulators [18]. )e dual activator effect of P2 is in
agreement with previous literature [19].
)e other two isolates, namely, P1 and P3, showed no
PPAR agonistic activity. However, this is the first report of
the PPAR agonistic activity of the PCME and P2.
From the results shown in Table 2, it could be seen that
the PCME, P1, P2, and P3 showed decrease in oxidative
stress. )e largest decrease in oxidative stress was exhibited
by the PCME (66% decrease at 500 µg/mL), which may be
attributed to its constituents (mainly the flavane gallates and
flavonoids). All three constituents P1, P2, and P3 showed
decrease in oxidative stress by 60%, 52%, and 57%, re-
spectively, at 250 µg/mL. )is indicates that the significant
antioxidant effect of the PCME seems to be due to its high
phenolic content. Flavonoids are polyphenolic substances
with free-radical scavenging properties that can inhibit
oxidative enzymes and demonstrate anti-inflammatory ac-
tion [3].
)e other targets related to anti-inflammatory activity
were only weakly to moderately affected by the PCME, such
as that shown by inhibition of the nuclear transcription
factor NF-kB and inducible nitric oxide synthase (iNOS)
(Table 2). Interestingly, P2 showed iNOS inhibition while P3
did not show any. P1 was the most active iNOS inhabitant
with IC50 of 25 µg/mL.
All tested compounds P1, P2, and P3 from the P. cur-
viflorus were not cytotoxic although PCME showed weak
activity against all four cancerous cell lines as well as the two
normal cell lines with the IC50 values ranging from 70–92 μg/
mL (Table 3). )is may refer to the synergistic activity of
polyphenolic constituents present among them.
Several studies have reported that flavonoids and flavane
gallates suppress the activity of the pathogenic microor-
ganisms [20–22]. In this study, the PCME and P1 showed
significant antibacterial effect against both Gram-positive
and Gram-negative bacteria as compared to amikacin (Ta-
ble 4), the reference standard. )e highest activity was
recorded for P1 against both Klebsiella pneumonia (ATCC
700603) and Pseudomonas aeruginosa (ATCC 27853) with
MIC of 6.2 and 6.6 µg/mL, respectively, followed by the
activity of PCME against Bacillus cereus (ATCC 14579) and
Pseudomonas aeruginosa (ATCC 27853) with MIC of 7.6
and 8.4 µg/mL, respectively, while P2 showed the lowest
activity and P3 showed any noticeable inhibition.
3.2. HPTLC Method Development and Validation.
Different solvent compositions were analyzed in order to
choose the appropriate mobile phase for HPTLC analysis.
Out of these, a mixture of dichloromethane :methanol :
formic acid in the ratio of 90 : 9.5 : 0.5 (v/v/v) was found to
be the most effective mobile phase for the estimation P1,
P2,and P3. Sharp and compact peaks of P1, P2, and P3 took
place at Rf � 0.34, 0.47, and 0.65, respectively (Figure 2(a)),
with good separation of the biomarkers from the matrix and
other several constituents of the PCME (Figure 2(b)). 20mL
and 20min were the optimized mobile phase volume for
saturation and saturation time, respectively. High-resolution
baseline affects the selectivity of our developed method. )e
identities of the bands of the extracts were confirmed by
overlaying their spectra along with the spectra of standards
(Figure 2(d)). )e regression equation/square of correlation
coefficients (r2) for P1, P2, and P3 were found as
Y� 2.725X+ 122.44/0.993, Y� 1.675X+ 755.87/0.993, and
Y � 52.008X + 211.51/0.9972, respectively, in the linearity
range 100–1200 ng/spot. )e limit of detection (LOD) and
limit of quantification (LOQ) were found as 31.04/94.06,
29.23/88.58, and 12.33/37.36, respectively, for P1, P2,
and P3 (Table 5). )e accuracy values of the proposed
method for estimation of P1, P2, and P3 were observed in
terms of % recovery and %RSD, as listed in (Table 6). )e
recovery/RSD (%) for P1, P2, and P3 was found as
98.89–99.72/1.25–1.35, 98.57–99.07/1.41–1.52, 98.36-
99.22/1.21–1.36, respectively (Table 5). )e %RSD for
intraday/interday precisions (n � 6) were detected as
1.15–1.20/1.11–1.20, 1.17–1.27/1.12–1.21, and 1.27–1.33/
1.271.32 respectively, for P1, P2, and P3 which
4 Journal of Analytical Methods in Chemistry
exhibited good precision of the proposed method (Ta-
ble 7). )e robustness study was determined by in-
troducing little deliberate changes in the mobile phase
constituent, saturation duration time, and the volume of
mobile phase, and the recorded data in the form of SD and
%RSD values are listed in Table 8. )e low values of SD and
%RSD showed that the proposed method was robust.
3.3. Estimation of P1, P2, and P3 in PCME by HPTLC.
)e developed HPTLC technique was used for quantitative
analysis of P1, P2, and P3 in PCME.)ese biologically active
markers were found to be present in PCME (Figure 2(c)).
)e quantities (μg/mg of the dried weight of extracts) of
biomarkers P1, P2, and P3 in PCME were found in the
following order: 11.06> 10.9> 6.96 μg/mg (Table 9). )is
Table 2: Anti-inflammatory activity of PCME and P1, P2, and P3.
aSample name % decrease in oxidative stress iNOS inhibition (IC50; µg/mL) NF-kB inhibition (IC50; µg/mL)
PCME 66 NA NA
P1 52 48 NA
P2 39 >50 NA
P3 57 NA NA
Quercetin (50 µM)b 75 — —
Parthenolideb — 0.35± 0.22 0.5± 0.21
aAt 500 µg/mL for the extract and 250 µg/mL for pure compounds. bPositive control. NA�no activity up to 100 µg/mL (NF-kB, iNOS) and 500 µg/mL
(oxidative stress).
Table 3: Cytotoxicity of PCME and P1, P2, and P3.
Sample name
Cancer cells (IC50; µg/mL) Noncancer cells (IC50; µg/mL)
SK-MEL KB BT-549 SK-OV-3 VERO LLC-PK11
PCME 76 60 92 70 70 70
P1 NA NA NA NA NA 55
P2 NA NA NA NA NA 16
P3 NA NA NA NA NA NA
Doxorubicin 1.23 1.85 1.93 0.8 >5 0.85
NA�no cytotoxic activity upto 100 µg/mL.
Table 4: Antibacterial activity of PCME and P1, P2, and P3.
Bacterial strain
ZOI diameter (mm) MIC (µg/mL)
PCME P1 P2 P3 AMK PCME P1 P2 P3 AMK
Gram −
K. pneumonia 13± 1.8 21.3± 1.15 — — 25± 0.8 10 6.2 — — 5
E. fergusonii 17± 0.5 16.3± 0.57 8± 1 — 24± 1.5 8.9 9.3 11 — 4.5
P. aeruginosa 18± 1.2 21± 1 — — 18± 1.3 8.4 6.6 — — 8
Gram +
S. aureus 16± 1.6 18± 1 — — 24± 1 9.2 8.3 — — 6.2
B. cereus 20± 0.5 19.3± 1.15 — — 20± 0.9 7.6 8.4 — — 7.3
Results are expressed as mean± standard deviation (SD).
Table 1: PPAR agonistic activity of PCME and P1, P2, and P3.
Sample name
Fold induction
PPAR alpha PPAR gamma
50 µg/mL 25 µg/mL 12.5 µg/mL 50 µg/mL 25 µg/mL 12.5 µg/mL
PCME 1.50 1.31 1.21 1.90 1.90 1.60
P1 NA NA NA NA NA NA
P2 1.47 1.31 1.19 1.53 1.55 1.19
P3 NA NA NA NA NA NA
Ciprofibrate (10 µM) 2.2 NT
Rosiglitazone (10 µM) NT 3.7
NA�not active.
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nding indicated that P1 is the highest quantity of all the
biomarkers followed by P2 and P3 in the PCME.
Dierent analytical techniques such as HPLC, HPTLC
had been reported for the quantitative analysis of quer-
cetin in many plant extracts such as detection of quercetin
by the HPTLC method in the aerial parts of Leea indica
[23] and espesia populnea L. [24]. To our knowledge,
this is the rst report of concurrent estimation of quer-
cetin (P1), 2S,3R-3,3′,4′,5,7-pentahydroxyavane-5-O-
gallate (P3), and (-)-catechin (P2) in P. curviorus.
Hence, we are privileged to report this maiden research
on the screening of antidiabetic, cardiovascular, anti-
inammatory, and cytotoxic biomarkers in the metha-
















































































































































Figure 2: Quantication of P1, P2, and P3 in PCME by HPTLC at λ 460 nm (mobile phase: dichloromethane :methanol : formic acid (90 :
9.5 : 0.5)). (a) Chromatogram of standard P3 (Rf 0.34), P2 (Rf 0.47), and P1 (Rf 0.65). (b) 3D display of all tracks. (c) Chromatogram of
PCME (P3, spot 6, Rf 0.34; P2, spot 7, Rf 0.47; P1, spot 8, Rf 0.65). (d) Spectral comparison of all the tracks at 460 nm.
Table 5: Rf and linear regression data for the calibration curve of P1, P2, and P3 (n 6).
Parameters P1 P2 P3
Linearity range (ng/spot) 100–1200 100–1200 100–1200
Regression equation Y 2.725X+ 122.44 Y 1.675X+ 755.87 Y 2.008X+ 211.51
Correlation (r2) coe¬cient 0.993± 0.001 0.993± 0.001 0.9972± 0.001
Slope± SD 2.725± 0.025 1.675± 0.014 2.008± 0.007
Intercept± SD 122.44± 9.30 755.87± 10.07 211.51± 12.75
Standard error of slope 0.005 0.006 0.003
Standard error of intercept 3.795 4.11 5.206
Rf 0.65± 0.004 0.47± 0.003 0.34± 0.001
LOD (ng) 31.04 29.23 12.33
LOQ (ng) 94.06 88.58 37.36
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4. Conclusion
Compounds P1, P2, and P3 have been isolated from the
methanolic extract of the leaves of P. curviflorus. All
compounds and the extract showed significant antioxidant
activities. Catechin (P2) and the methanol extract (PCME)
revealed dual PPAR activation effect, while compound P1
possesses the most potential anti-inflammatory activity.
)e maiden HPTLC method was developed for the si-
multaneous analysis of the biomarker compounds quer-
cetin (P1), (-)-catechin (P2), and 2S,3R-3,3′,4′,5,7-
pentahydroxyflavane-5-O-gallate (P3) in the methanol
extract of P. curviflorus (PCME). )e proposed HPTLC
method can be further applied for the analysis of these
compounds P1, P2, and P3 in different plant extracts,
biological samples, and herbal formulations as well as for
the in-process quality control.
Data Availability
)e data used to support the findings of this study are
available from the corresponding author upon request.
Conflicts of Interest
)e authors declare that there are no conflicts of interest.
Table 6: Recovery as accuracy studies of the proposed HPTLC method (n� 6).
Percent of P1, P2,



























0 200 197.78± 2.57 1.29 98.89 198.14± 2.79 1.41 99.07 196.72± 2.38 1.21 98.36
50 300 296.07± 3.72 1.25 98.69 296.65± 4.37 1.47 98.88 297.66± 3.67 1.23 99.22
100 400 398.88± 5.31 1.33 99.72 396.25± 5.91 1.49 99.06 396.17± 5.29 1.33 99.04
150 500 495.02± 6.73 1.35 99.01 492.85± 7.54 1.52 98.57 494.28± 6.73 1.36 98.85





































200 197.78± 2.29 1.15 194.47± 2.17 1.11 198.02± 2.33 1.17 196.23± 2.21 1.12 198.12± 2.53 1.27 193.14± 2.47 1.27
400 395.94± 4.77 1.20 392.27± 4.63 1.18 396.45± 4.77 1.20 392.87± 4.59 1.16 396.31± 5.21 1.31 393.32± 5.19 1.31
600 597.81± 7.17 1.19 594.14± 7.15 1.20 594.10± 7.59 1.27 591.72± 7.17 1.21 594.75± 7.95 1.33 592.26± 7.85 1.32
Table 8: Robustness of the proposed HPTLC method (n� 6).
Optimization condition
P1 P2 P3
SD %RSD SD %RSD SD %RSD
Mobile phase composition (dichloromethane :methanol : FA� 90 : 9.5 : 0.5)
90 : 9.5 : 0.5 3.51 1.18 3.31 1.12 4.26 1.42
89.5 :10 : 0.5 3.57 1.19 3.37 1.15 4.29 1.44
90.5 : 9 : 0.5 3.62 1.21 3.41 1.18 4.37 1.46
Mobile phase volume (for saturation)
18mL 3.34 1.13 3.62 1.23 4.17 1.40
20mL 3.38 1.14 3.67 1.25 4.23 1.43
22mL 3.42 1.16 3.69 1.27 4.31 1.45
Duration of saturation
10min 3.45 1.16 3.21 1.08 4.01 1.35
20min 3.49 1.18 3.26 1.09 4.03 1.36
30min 3.52 1.19 3.31 1.10 4.09 1.38
Table 9: HPTLC analysis of P1, P2, and P3 in PCME.
S.
No. Sample
P1 content (µg/mg of dried weight of
extract)
P2 content (µg/mg of dried weight of
extract)
P3 content (µg/mg of dried weight of
extract)
1 PCME 11.06± 0.86 10.9± 0.77 6.96± 0.41
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